These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36320143)

  • 1. Temsirolimus Adventitial Delivery to Improve ANGiographic Outcomes Below the Knee.
    Cawich I; Armstrong EJ; George JC; Golzar J; Shishehbor MH; Razavi M; Lee V; Ouriel K
    J Endovasc Ther; 2024 Aug; 31(4):562-575. PubMed ID: 36320143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six-Month Outcomes From the First-in-Human, Single-Arm SELUTION Sustained-Limus-Release Drug-Eluting Balloon Trial in Femoropopliteal Lesions.
    Zeller T; Brechtel K; Meyer DR; Noory E; Beschorner U; Albrecht T
    J Endovasc Ther; 2020 Oct; 27(5):683-690. PubMed ID: 32666871
    [No Abstract]   [Full Text] [Related]  

  • 3. Six-Month Angiographic and Clinical Outcomes of Therapeutic Ultrasound Pretreatment Associated With Plain Balloon Angioplasty for Below-the-Knee Lesions in Patients With Critical Limb Ischemia: A Prospective, Single-Center Pilot Study.
    Del Giudice C; Gandini R
    J Endovasc Ther; 2019 Apr; 26(2):191-198. PubMed ID: 30741077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-coated balloon versus uncoated percutaneous transluminal angioplasty for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal artery: 2-year results of the MDT-2113 SFA Japan randomized trial.
    Iida O; Soga Y; Urasawa K; Saito S; Jaff MR; Wang H; Ookubo H; Yokoi H;
    Catheter Cardiovasc Interv; 2019 Mar; 93(4):664-672. PubMed ID: 30747489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acotec Drug-Coated Balloon Catheter: Randomized, Multicenter, Controlled Clinical Study in Femoropopliteal Arteries: Evidence From the AcoArt I Trial.
    Jia X; Zhang J; Zhuang B; Fu W; Wu D; Wang F; Zhao Y; Guo P; Bi W; Wang S; Guo W
    JACC Cardiovasc Interv; 2016 Sep; 9(18):1941-9. PubMed ID: 27659572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-month pivotal results of tack optimized balloon angioplasty using the Tack Endovascular System in below-the-knee arteries.
    Geraghty PJ; Adams G; Schmidt A;
    J Vasc Surg; 2021 Mar; 73(3):918-929.e5. PubMed ID: 32956797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-Coated Balloon Treatment of Femoropopliteal Lesions for Patients With Intermittent Claudication and Ischemic Rest Pain: 2-Year Results From the IN.PACT Global Study.
    Micari A; Brodmann M; Keirse K; Peeters P; Tepe G; Frost M; Wang H; Zeller T;
    JACC Cardiovasc Interv; 2018 May; 11(10):945-953. PubMed ID: 29798770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-Year Sustained Clinical Efficacy of Drug-Coated Balloon Angioplasty in a Real-World Femoropopliteal Cohort.
    Torsello G; Stavroulakis K; Brodmann M; Micari A; Tepe G; Veroux P; Benko A; Choi D; Vermassen FEG; Jaff MR; Guo J; Dobranszki R; Zeller T;
    J Endovasc Ther; 2020 Oct; 27(5):693-705. PubMed ID: 32583749
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study.
    Reijnen MMPJ; van Wijck I; Zeller T; Micari A; Veroux P; Keirse K; Lee SW; Li P; Voulgaraki D; Holewijn S
    J Endovasc Ther; 2019 Jun; 26(3):305-315. PubMed ID: 30931726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of drug-coated balloon angioplasty versus uncoated balloon angioplasty in treatment of total occlusions with severe femoropopliteal lesions: An additional analysis from the AcoArt I study.
    Sun G; Liu J; Jia S; Zhang J; Zhuang B; Jia X; Fu W; Wu D; Wang F; Zhao Y; Guo P; Bi W; Wang S; Guo W;
    Vascular; 2021 Jun; 29(3):340-349. PubMed ID: 32903168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MagicTouch PTA Sirolimus Coated Balloon for Femoropopliteal and Below the Knee Disease: Results From XTOSI Pilot Study Up To 12 Months.
    Choke E; Tang TY; Peh E; Damodharan K; Cheng SC; Tay JS; Finn AV
    J Endovasc Ther; 2022 Oct; 29(5):780-789. PubMed ID: 34911383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Year Results of Paclitaxel-Coated Balloons for Long Femoropopliteal Artery Disease: Evidence From the SFA-Long Study.
    Micari A; Nerla R; Vadalà G; Castriota F; Grattoni C; Liso A; Russo P; Pantaleo P; Roscitano G; Cremonesi A
    JACC Cardiovasc Interv; 2017 Apr; 10(7):728-734. PubMed ID: 28385412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: the IDEAS randomized controlled trial.
    Siablis D; Kitrou PM; Spiliopoulos S; Katsanos K; Karnabatidis D
    JACC Cardiovasc Interv; 2014 Sep; 7(9):1048-56. PubMed ID: 25234679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MagicTouch PTA Sirolimus-Coated Balloon for Femoropopliteal and Below-the-Knee Disease: 3-Year Outcomes of the XTOSI Trial.
    Choke ETC; Peh EYL; Tang TY; Cheng SC; Tay JS; Aw DKL; Vijaykumar K
    Ann Vasc Surg; 2024 Sep; 106():8-15. PubMed ID: 38579912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A universal drug delivery catheter for the treatment of infrapopliteal arterial disease using liquid therapy.
    Bunch F; Nair P; Aggarwala G; Dippel E; Kassab E; Khan MA; LeCroy C; McClure JM; Tolleson T; Walker C
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):393-401. PubMed ID: 32017374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IN.PACT SFA Clinical Study Using the IN.PACT Admiral Drug-Coated Balloon in a Chinese Patient Population.
    Chen Z; Guo W; Jiang W; Wang F; Fu W; Zou Y; Deckers S; Li P; Popma JJ; Jaff MR
    J Endovasc Ther; 2019 Aug; 26(4):471-478. PubMed ID: 31204595
    [No Abstract]   [Full Text] [Related]  

  • 17. Paclitaxel-Coated Balloon in Infrapopliteal Arteries: 12-Month Results From the BIOLUX P-II Randomized Trial (BIOTRONIK'S-First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries).
    Zeller T; Beschorner U; Pilger E; Bosiers M; Deloose K; Peeters P; Scheinert D; Schulte KL; Rastan A; Brodmann M
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1614-22. PubMed ID: 26493253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 24-Month Results of the Lutonix Global SFA Registry: Worldwide Experience With Lutonix Drug-Coated Balloon.
    Thieme M; Von Bilderling P; Paetzel C; Karnabatidis D; Perez Delgado J; Lichtenberg M;
    JACC Cardiovasc Interv; 2017 Aug; 10(16):1682-1690. PubMed ID: 28780030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions.
    Laird JA; Schneider PA; Jaff MR; Brodmann M; Zeller T; Metzger DC; Krishnan P; Scheinert D; Micari A; Wang H; Masters M; Tepe G
    Circ Cardiovasc Interv; 2019 Jun; 12(6):e007702. PubMed ID: 31195825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The IN.PACT DEEP Clinical Drug-Coated Balloon Trial: 5-Year Outcomes.
    Zeller T; Micari A; Scheinert D; Baumgartner I; Bosiers M; Vermassen FEG; Banyai M; Shishehbor MH; Wang H; Brodmann M;
    JACC Cardiovasc Interv; 2020 Feb; 13(4):431-443. PubMed ID: 32081236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.